Article Information
History
- March 2, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sam AJ Wilkinson1,
- Alex Richter2,
- Anna Casey1,
- Husam Osman3,
- Jeremy D Mirza1,
- Joanne Stockton1,
- Josh Quick1,
- Liz Ratcliffe3,
- Natalie Sparks1,
- Nicola Cumley1,
- Radoslaw Poplawski1,
- Sam Nicholls1,
- Beatrix Kele4,
- Kathryn Harris4,
- The COVID-19 Genomics UK (COG-UK) consortium5,
- Thomas P Peacock6,* and
- Nicholas J Loman1,*
- 1Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, UK, B15 2TT
- 2Institute of Immunology and Immunotherapy (III), College of Medical and Dental Sciences, University of Birmingham, UK, B15 2TT
- 3Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham, UK, B15 2TH
- 4Virology Department, NHS East and South East London Pathology Partnership, Royal London Hospital, Barts Health NHS Trust, UK, EC1A 7BE
- 6Department of Infectious Disease, Imperial College London, London, UK, W2 1PG
- ↵*Corresponding Authors; email: n.j.loman{at}bham.ac.uk
Posted March 02, 2022.
